The first human genome was sequenced in 2001 at a cost of $3 billion. Today, human genome sequencing costs less than $1000, and in a few years the price will drop below $100. Thus, personal genome sequencing will soon be widely adopted as it enables better diagnosis, disease prevention, and personalized therapies. Furthermore, if genomic data is shared with researchers, the causes of many diseases will be identified and new drugs developed. These opportunities are creating a genomic data market worth billions of dollars.
For the first time, researchers have found rare #genetic mutations that can cause #lupus. This is a significant step towards #PrecisionMedicine treatments of lupus and other autoimmune diseases that these variants are linked to (including type 1 diabetes). https://t.co/X1W87dEUfz
Are you a #dog person? A study of twins suggests that #genetics has a significant influence on dog ownership. More work is needed to find the mechanisms underlying this relationship, such as whether they relate to the genetics of personality or allergies. https://t.co/G3HM2up2uA
Scientists synthesize ('write') a complete (bacterial) genome, and while they were at it, recoded it. Words like 'milestone' and 'landmark' are being thrown around: https://t.co/avRaGKyTT7 #synbio @nature @GP_write
If you find store-bought #tomatoes to be lacking in flavor, good news: scientists may have found the culprit. Using genomic info from 725 #tomato breeds, they've found a #genetic variant that improves flavor that's missing from 93% of domesticated breeds. https://t.co/px5m2Qzvo0